港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

中慧生物-B

52.800

+0.2000.38%

成交量：26.48万

成交额：1,388.28万

市值：207.74亿

市盈率：-67.32

高：53.950

开：53.950

低：51.400

收：52.600

52周最高：59.600

52周最低：33.000

股本：3.93亿

香港流通股本：2.96亿

量比：0.84

换手率：0.09%

股息：- -

股息率：- -

每股收益(LYR):-0.784

净资产收益率：--

总资产收益率：--

市净率：306.16

市盈率(LYR):-67.32

市销率: 73.29

数据加载中...

总览公司新闻公告

中慧生物：因恶劣天气，港股上市日期推迟到8月11日

老虎资讯综合

中慧生物：因暴雨推迟上市

《新股》中慧生物(02627.HK)因恶劣天气延长招股期至下周一挂牌上市

阿斯达克财经

中慧生物(2627.HK)孖展暂超购逾1793倍

新股孖展统计 | 8月4日

中慧生物-B孖展超购1100倍引爆市场！创新疫苗龙头本周五登陆港交所

老虎资讯综合

创新药热潮延续，疫苗公司中慧生物-B孖展超购1135倍

老虎资讯综合

【券商聚焦】国证国际予中慧生物(02627)IPO专用评分“5.3” 指其估值水平偏高

港股IPO动态：今日中慧生物申购

港股IPO周报：726倍！中慧生物-B再续18A佳绩？IPO新规采取发行人“二选一”模式

IPO定价谨慎、短期基本面短板明显，中慧生物-B（02627）或拉低投资者“打新收益”

新股招股 | 中慧生物-B于7月31日至8月5日招股，一手认购金额3131.26港元

【新股IPO】中慧生物-B(02627)今日起招股入场费3,131.26港元

《新股》中慧生物(02627.HK)今起招股入场费3,131.26元

阿斯达克财经

中慧生物-B(02627.HK)于7月31日至8月5日招股拟全球发售3344.26万股H股

中慧生物-B(02627.HK)拟全球发售3344.26万股H股预计8月8日上市

【上市公司】中国速冻食品集体出海：安井A+H领航海外增量市场成新引擎

上市公司网

【上市公司】麦加芯彩跻身全球涂料第54名、国内涂料第5名：多板块发力铸就行业新势能

上市公司网

香港证券市场下调最低上落价位；美国公司AIWB递表港交所丨港交所早参

每日经济新闻

仅一款疫苗获批，中慧生物再闯港交所

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02627/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":52.8,"timestamp":1756186951908,"preClose":52.6,"halted":0,"volume":264800,"delay":0,"floatShares":296361845,"shares":393442600,"eps":-0.7842596882100777,"marketStatus":"交易中","change":0.2,"latestTime":"08-26 13:42:34","open":53.95,"high":53.95,"low":51.4,"amount":13882810,"amplitude":0.048479,"askPrice":52.9,"askSize":400,"bidPrice":52.8,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.8569700353252595,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":52.6,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.839272,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.78426,"volumeRatio":0.839272,"shares":393442600,"dividePrice":0,"high":53.95,"amplitude":0.048479,"preClose":52.6,"low":51.4,"week52Low":33,"pbRate":"306.16","psRate":"73.29","week52High":59.6,"institutionHeld":0,"latestPrice":52.8,"committee":-0.333333,"eps":-0.7842596882100777,"divideRate":0,"volume":264800,"delay":0,"ttmEps":-0.8569700353252595,"open":53.95,"prevYearClose":12.9,"prevWeekClose":51.5,"prevMonthClose":12.9,"prevQuarterClose":12.9,"fiveDayClose":51.55,"twentyDayClose":12.9,"sixtyDayClose":12.9,"earningDate":1756310400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2025-08-25","current":-67.012733,"percent":0.090909,"low":-68.430715,"twenty":-66.312405,"median":-63.829854,"eighty":-55.968526,"high":-18.07815,"avg":-57.901075,"sd":13.845669,"marketCap":20695080760},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-25","current":-67.012733,"twenty":-66.312405,"median":-63.829854,"eighty":-55.968526,"marketCap":20695080760}],"updateTime":1756186954113},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134872702","title":"中慧生物：因恶劣天气，港股上市日期推迟到8月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=1134872702","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134872702?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 12:44","pubTimestamp":1754369046,"startTime":"0","endTime":"0","summary":"原定于8月8日。","market":"hk","thumbnail":"https://static.tigerbbs.com/bde42f30679fdd5f60f8889efddc73f5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bde42f30679fdd5f60f8889efddc73f5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"58064b50446765aa6b3cf643914e23ca","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"2557235107","title":"中慧生物：因暴雨推迟上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2557235107","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557235107?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 12:06","pubTimestamp":1754366798,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"58064b50446765aa6b3cf643914e23ca","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02627","HEXmain"],"gpt_icon":0},{"id":"2557354834","title":"《新股》中慧生物(02627.HK)因恶劣天气延长招股期 至下周一挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2557354834","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557354834?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 12:01","pubTimestamp":1754366460,"startTime":"0","endTime":"0","summary":"疫苗公司中慧生物(02627.HK)宣布，由于黑色暴雨警告及今日(5日)上午恶劣天气导致的极端情况，招股章程及正式通告所载的全球发售预期时间表将推迟，招股期将延至明日(6日)中午才结束，预期定价日为周四(7日)，并计划于下周一(11日)挂牌上市。中慧生物原定于7月31日至今日招股，并于8月8日挂牌上市。(gc/j)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250801150906485_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250801150906485_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1458525/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02627"],"gpt_icon":0},{"id":"2556389114","title":"中慧生物(2627.HK)孖展暂超购逾1793倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2556389114","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556389114?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 20:01","pubTimestamp":1754308872,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["CYB","BK0028","06030","BK1564","CNHmain","BK0188","LU1064131003.USD","BK1147","MCNHmain","02627","LU0405327494.USD","UCmain","MUCmain","LU1720050803.USD","BK0012","600030","BK0196","LU1794554557.SGD","LU1997245177.USD","LU2289578879.USD","LU1997244956.HKD","LU1997245094.SGD","BK0183","LU2495084118.USD","BK1521","LU1064130708.USD","BK1516","BK0276","LU2148510915.USD","LU1655091616.SGD","LU0405327148.USD","LU1328615791.USD","159646"],"gpt_icon":0},{"id":"2556388172","title":"新股孖展统计 | 8月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2556388172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556388172?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 18:36","pubTimestamp":1754303778,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中慧生物-B(02627)正在招股中。截止8月4日，富途、辉立、华盛等券商合计为中慧生物-B借出931.1925亿港元，超购逾1789倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":0},{"id":"1199568054","title":"中慧生物-B孖展超购1100倍引爆市场！创新疫苗龙头本周五登陆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=1199568054","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199568054?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 13:31","pubTimestamp":1754285473,"startTime":"0","endTime":"0","summary":"创新药热潮持续，创新疫苗企业中慧生物-B孖展超购1100倍，融资申购金额超588亿港元，公司于本周五正式登陆港交所。其中，“慧尔康欣”四价流感疫苗于2023年获批上市，是中国首款也是唯一一款同类疫苗，主要用于三岁及以上人群。狂犬疫苗基于人二倍体细胞开发，已完成I期临床，计划于2025年第三季度启动III期临床试验。财务概况公司2023年和2024年收入分别为5220万元和2.6亿元，均来自四价流感疫苗。2025年前一季度亏损扩大至8730万元。","market":"us","thumbnail":"https://static.tigerbbs.com/266ab84342c6ca65b538d0b42bc1dc4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/266ab84342c6ca65b538d0b42bc1dc4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f2d1ebbc349e985f4ad6983540025d5d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEXmain","02627","159645"],"gpt_icon":0},{"id":"1154863128","title":"创新药热潮延续，疫苗公司中慧生物-B孖展超购1135倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1154863128","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154863128?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 12:35","pubTimestamp":1754282113,"startTime":"0","endTime":"0","summary":"融资申购金额588.6亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/bde42f30679fdd5f60f8889efddc73f5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bde42f30679fdd5f60f8889efddc73f5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f2d1ebbc349e985f4ad6983540025d5d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":1},{"id":"2556746218","title":"【券商聚焦】国证国际予中慧生物(02627)IPO专用评分“5.3” 指其估值水平偏高","url":"https://stock-news.laohu8.com/highlight/detail?id=2556746218","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556746218?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 10:57","pubTimestamp":1754276273,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国证国际发布中慧生物 IPO点评，指公司成立于2015年，是一家疫苗公司，致力于创新疫苗及采用新技术方法的传统疫苗的研发。该机构指，中慧生物目前就一款疫苗上市，其他管线进展较快的狂犬疫苗即将进入III期临床。公司此次IPO发行价为12.9-15.5港元，发行后市值约50.75-60.98亿港元。参考港股疫苗公司康希诺生物和艾美疫苗，公司估值水平偏高。结合基石投资者、公司估值、地位、医药市场打新热度高等因素，该机构给予公司IPO专用评分“5.3”。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/YjE3MzU0MjU2ODIzMjIz.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjE3MzU0MjU2ODIzMjIz.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f2d1ebbc349e985f4ad6983540025d5d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1963363","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":1},{"id":"2556731198","title":"港股IPO动态：今日中慧生物申购","url":"https://stock-news.laohu8.com/highlight/detail?id=2556731198","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556731198?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 06:06","pubTimestamp":1754258804,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02627"],"gpt_icon":0},{"id":"2556722827","title":"港股IPO周报：726倍！中慧生物-B再续18A佳绩？IPO新规采取发行人“二选一”模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2556722827","media":"活报告","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556722827?lang=zh_cn&edition=fundamental","pubTime":"2025-08-03 17:01","pubTimestamp":1754211660,"startTime":"0","endTime":"0","summary":"截至8月3日，孖展认购倍数已超726倍，不知是否可以再续18A佳绩？同时，港交所决定保留现有的基石投资6个月禁售期规定，以维持投资者对发售的承诺。公司是致力于研发流感疫苗的生物医药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-08-03/doc-infitaat6642896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02631","BK4614","YANG","02627","HSCEI","HSTECH"],"gpt_icon":1},{"id":"2555004403","title":"IPO定价谨慎、短期基本面短板明显，中慧生物-B（02627）或拉低投资者“打新收益”","url":"https://stock-news.laohu8.com/highlight/detail?id=2555004403","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555004403?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 15:42","pubTimestamp":1753947722,"startTime":"0","endTime":"0","summary":"然而，虽有保荐人光环，依旧难掩中慧生物短期的基本面短板，投资者还是难以“闭眼打新”。另外，此次中慧生物IPO缺乏明星基石阵容也值得投资者注意。招股书显示，2024年，中慧生物退货负债高达8470万元，暗示公司存在的显著库存压力，利润侵蚀情况有待改善。因此，中慧生物或许只适合高风险偏好的投资者进行博弈，对于普通投资者而言，“闭眼打新”则存在不小风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":1},{"id":"2555078716","title":"新股招股 | 中慧生物-B于7月31日至8月5日招股，一手认购金额3131.26港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555078716","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555078716?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 10:00","pubTimestamp":1753927233,"startTime":"0","endTime":"0","summary":"中慧生物今日起至8月5日招股，每股招股价12.9至15.5元，发售3344.26万股，香港公开发售佔10%，其馀为国际配售，集资最多5.18亿元。每手200股，一手入场费3131.26元。中慧生物预期将于8月8日挂牌，中信証券、招银国际为联席保荐人。截至最后实际可行日期，集团的产品管线包括两种核心产品，即四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗，以及其他11种在研疫苗。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/4896ba892092c1c2e6989f8918a50511","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4896ba892092c1c2e6989f8918a50511"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e19b3a7a384068fd61353f6bfc7f22e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323887.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股 | 中慧生物-B于7月31日至8月5日招股，一手认购金额3131.26港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":1},{"id":"2555987075","title":"【新股IPO】中慧生物-B(02627)今日起招股 入场费3,131.26港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555987075","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555987075?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 08:35","pubTimestamp":1753922110,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中慧生物-B(02627)今日起招股，拟发行3344.26万股H股，其中90%为国际发售，10%为香港发售，另有15%超额配股权。每股招股价介于12.9港元至15.5港元，每手200股，入场费3,131.26港元。中信证券、招银国际为联席保荐人。股份预期将于8月8日挂牌上市。以中间价14.2港元计算，预期集资净额约4.21亿港元，公司拟将其中约63.6%将分配至集团的核心产品的开发及国内外注册；约18.1%将用于集团的其他在研疫苗的开发和注册；约8.4%将分配至改进集团的工艺及商业化能力；约4.9%将分配至集团的技术平台的开发；及约5%将分配至营运资金及其他一般公司用途。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NzQzNDA1NDU2OTQ1Mw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NzQzNDA1NDU2OTQ1Mw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e19b3a7a384068fd61353f6bfc7f22e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1963192","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"2555789075","title":"《新股》中慧生物(02627.HK)今起招股 入场费3,131.26元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555789075","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555789075?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 08:27","pubTimestamp":1753921620,"startTime":"0","endTime":"0","summary":"疫苗公司江苏中慧元通生物科技在港进行首次公开发售，计划全球发售3,344.26万股H股，香港公开发售占10%，国际配售部分占90%，发售价介乎每股12.9至15.5元，最多集资约5.18亿元。每手买卖单位200股，入场费约3,131.26元。招股期由今日起至下周二止，预计将于8月8日挂牌上市，由中信证券及招银国际担任联席保荐人。是次IPO引入嘉兴鑫扬及华泰资本投资为基石投资者，将认购约1,300万美元等值股份。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250731082848657_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250731082848657_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e19b3a7a384068fd61353f6bfc7f22e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1457315/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02627"],"gpt_icon":0},{"id":"2555712078","title":"中慧生物-B(02627.HK)于7月31日至8月5日招股 拟全球发售3344.26万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555712078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555712078?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 07:35","pubTimestamp":1753918533,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e19b3a7a384068fd61353f6bfc7f22e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02627"],"gpt_icon":0},{"id":"2555605078","title":"中慧生物-B(02627.HK)拟全球发售3344.26万股H股 预计8月8日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2555605078","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555605078?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 06:52","pubTimestamp":1753915967,"startTime":"0","endTime":"0","summary":"格隆汇7月31日丨中慧生物-B发布公告，公司拟全球发售3344.26万股H股，中国香港发售股份334.44万股，国际发售股份3009.82万股；2025年7月31日至8月5日招股，预期定价日为8月6日；发售价将为每股发售股份12.90-15.50港元，每手买卖单位为200股，中信证券及招银国际为联席保荐人；预期股份将于2025年8月8日开始在联交所买卖。假设发售价为每股发售股份14.20港元，基石投资者将予认购的发售股份总数将为711.36万股H股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/31065252100507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02627"],"gpt_icon":0},{"id":"2555051591","title":"【上市公司】中国速冻食品集体出海：安井A+H领航 海外增量市场成新引擎","url":"https://stock-news.laohu8.com/highlight/detail?id=2555051591","media":"上市公司网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555051591?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 18:32","pubTimestamp":1753785150,"startTime":"0","endTime":"0","summary":"中国上市公司网当国内速冻食品市场陷入\"内卷\"红海，头部企业正以\"出海\"为支点，撬动全球增量空间。企业竞速：多路径布局全球市场安井食品：7月4日，速冻食品龙头企业安井食品正式在港交所挂牌上市，正式开启“A+H”双资本平台战略。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729204446a469b478&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729204446a469b478&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","02648","603345","603536","BK0238"],"gpt_icon":0},{"id":"2555051370","title":"【上市公司】麦加芯彩跻身全球涂料第54名、国内涂料第5名：多板块发力铸就行业新势能","url":"https://stock-news.laohu8.com/highlight/detail?id=2555051370","media":"上市公司网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555051370?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 18:32","pubTimestamp":1753785150,"startTime":"0","endTime":"0","summary":"中国上市公司网近日，《涂界》发布的“2025年全球涂料企业100强排行榜”揭晓，麦加芯彩以2.976亿美元销售收入位列第54位、国内企业第五名，创历史新高。这一成绩的背后，是麦加芯彩在海洋装备、新能源、基础建设等领域的深耕与突破，更是其从“单项冠军”向“综合型涂料强企”转型的实力印证。新兴赛道突破，认证与市场双线推进在船舶涂料领域，麦加芯彩正从“间接覆盖”向“直接突破”迈进。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729204438a469b46c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729204438a469b46c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","02627","603062"],"gpt_icon":0},{"id":"2555705580","title":"香港证券市场下调最低上落价位；美国公司AIWB递表港交所丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2555705580","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555705580?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 00:17","pubTimestamp":1753719454,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K5JHIRLL0512B07B.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K5JHIRLL0512B07B.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02627"],"gpt_icon":0},{"id":"2555370422","title":"仅一款疫苗获批，中慧生物再闯港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2555370422","media":"贝壳财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555370422?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 21:39","pubTimestamp":1753709940,"startTime":"0","endTime":"0","summary":"江苏中慧元通生物科技股份有限公司（简称“中慧生物”）近日再次向港交所递交招股书。这是该公司继今年1月23日递表港交所失效后的再度冲刺，也是其第三次冲击上市。据悉，中慧生物已获中国 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20250728/c669961377.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20250728/c669961377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159646","02627"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":89,"code":"91000000","status":"200"}]}}